UBC and cancer: Attractive alternatives to overcome the limitations of proteasome inhibitors are offered by other components of the ubiquitin conjugation system and its upstream regulators, such as the E1–E2–E3 enzyme cascade or DUB enzymes, which have also been used as targets for cancer treatment [102, 126, 127, 128, 129, 130].